A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

Condition:   C-staged Hepatocellular Carcinoma in BCLC Classification Intervention:   Combination Product: Hepatic Arterial Infusion combined with Apatinib and Camrelizumab Sponsors:   Sun Yat-sen University;   Jiangsu HengRui Medicine Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials